24 March 2015 CHE Partnership call: A High Price to Pay: Burden of Disease and Costs of Endocrine Disrupting Chemicals in the European Union.

This call discussed the significant new papers published March 6th in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism on the Burden of Disease and Costs of Endocrine Disrupting Chemicals in the European Union. The new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion a year in actual health care expenses and lost earning potential.